Artiva Biotherapeutics, Inc. (ARTV)

SEC filing

Artiva Biotherapeutics, Inc.

ARTV · CIK 1817241

4 · Aug 31, 2026 · Chief Medical Officer Banerjee Subhashis sold 8,222 shares at $12.01/share ($98,736); exercised options for 10.61K shares

Chief Medical Officer Banerjee Subhashis sold 8,222 shares at $12.01/share ($98,736); exercised options for 10.61K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).